Next Article in Journal
The Design and Cell-Free Protein Synthesis of a Pembrolizumab Single-Chain Variable Fragment
Previous Article in Journal
Quis Custodiet? Are Regulations Slowing Phage Therapy?
 
 
Conference Report
Peer-Review Record

32nd Annual GP2A Medicinal Chemistry Conference

Drugs Drug Candidates 2025, 4(1), 2; https://doi.org/10.3390/ddc4010002
by Jean-Jacques Hélesbeux 1, Florence O. McCarthy 2, Maria Manuel Silva 3,4, Alcino J. Leitão 3,4, Anthony Burke 3,5, Jorge A. R. Salvador 3,4, Rui Moreira 6, Emília Sousa 7,8, Vânia M. Moreira 3,4,* and Pascal Marchand 9,*
Drugs Drug Candidates 2025, 4(1), 2; https://doi.org/10.3390/ddc4010002
Submission received: 4 December 2024 / Accepted: 11 December 2024 / Published: 9 January 2025
Back to TopTop